Cogent Biosciences (COGT) Prepaid Assets (2017 - 2026)
Cogent Biosciences (COGT) recorded quarterly Prepaid Assets of $11.4 million in Q1 2026, up 19.13% quarter-over-quarter from $9.6 million in Q4 2025, and up 58.18% on a YoY basis from $7.2 million in Q1 2025.
Cogent Biosciences (COGT) Prepaid Assets (2017 - 2026) Analysis & Trends
Cogent Biosciences' Prepaid Assets history runs 10 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 58.18% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 58.18% YoY), while the FY2025 annual figure was $9.6 million, up 2.08% from the prior year.
- Prepaid Assets was $11.4 million for Q1 2026 at Cogent Biosciences, up from $9.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $11.4 million in Q1 2026 to a low of $3.7 million in Q1 2022.
- Historically, Prepaid Assets has averaged $6.5 million across 5 years, with a median of $6.2 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 177.14% in 2022, then fell 13.06% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $4.4 million in 2022, then rose by 14.11% to $5.1 million in 2023, then surged by 85.64% to $9.4 million in 2024, then increased by 2.08% to $9.6 million in 2025, then grew by 19.13% to $11.4 million in 2026.
- The last three Prepaid Assets figures came in at $11.4 million (Q1 2026), $9.6 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.43 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | 7.16 Mn |
| Mar 31, 2025 | 7.22 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 6.76 Mn |
| Mar 31, 2024 | 6.16 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | 6.91 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | 6.07 Mn |
| Jun 30, 2022 | 3.86 Mn |
| Mar 31, 2022 | 3.69 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | 4.62 Mn |
| Jun 30, 2021 | 3.25 Mn |